NCT/Study#

NCT04720664 /

OASIS

OASIS: Phase II trial of Oral SM-88 in patients with metastatic hormone receptor-positive HER2-negative (HR+/HER2-) breast cancer.

OASIS: Phase II trial of Oral SM-88 in patients with metastatic hormone receptor-positive HER2-negative (HR+/HER2-) breast cancer.

DISEASE GROUP:
Breast Cancer Clinical Trials
current phase:
Phase II
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: